The Swedish company that commercialized the first bio-based ink in 2016 has moved far beyond bioprinting and on-demand biofabrication of human organs and tissues, after completing six acquisitions of companies in other life-sciences specialties this year thus far. CELLINK Life Sciences has been renamed BICO Group. BICO is short for “bioconvergence,” the combination of biology, engineering and computer science technologies for healthcare and life-sci applications . . .